Thiotepa Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9309

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Thiotepa (NDC 0143-9309). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Thiotepa For Injection, Usp Structural Formula (Thiotepa For Injection Usp Novaplus 1)

Chemical structure of Thiotepa showing a phosphorus atom centrally bonded to three aziridine groups and a sulfur atom in a lyophilized injection form representation.*

FDA Label Image

Thiotepa For Injection, Usp Vial Label Image (Thiotepa For Injection Usp Novaplus 2)

Thiotepa 15 mg/1.5 mL injection powder lyophilized for solution vial label. Designed for intravenous, intracavitary, and intravesical use. Label includes proprietary name, strength, route of administration, labeler Hikma Pharmaceuticals USA Inc., and NDC 0143-9309.*

FDA Label Image

Representative Carton Serialization Image (Thiotepa For Injection Usp Novaplus 3)

Label for Thiotepa 15 mg/1.5 mL injection, lyophilized, for solution by Hikma Pharmaceuticals USA Inc. The label shows a 2D barcode and text including lot number, expiration date, GTIN, and serial number fields, formatted for tracking and identification.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.